61 related articles for article (PubMed ID: 23627488)
1. Quantification of Tumor Burden in a Genetically Engineered Mouse Model of Lung Cancer by Micro-CT and Automated Analysis.
Barck KH; Bou-Reslan H; Rastogi U; Sakhuja T; Long JE; Molina R; Lima A; Hamilton P; Junttila MR; Johnson L; Carano RA
Transl Oncol; 2015 Apr; 8(2):126-35. PubMed ID: 25926079
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of neutrophil-to-lymphocyte ratio (NLR) and platelet-neutrophil (PN) index in locally advanced rectal cancer patients: a retrospective cohort study.
Morais M; Fonseca T; Machado-Neves R; Honavar M; Coelho AR; Lopes J; Guerreiro E; Carneiro S
Ann Med Surg (Lond); 2024 May; 86(5):2474-2480. PubMed ID: 38694305
[TBL] [Abstract][Full Text] [Related]
3. KRAS activation in gastric cancer stem-like cells promotes tumor angiogenesis and metastasis.
Yoon C; Lu J; Jun Y; Suh YS; Kim BJ; Till JE; Kim JH; Keshavjee SH; Ryeom S; Yoon SS
BMC Cancer; 2023 Jul; 23(1):690. PubMed ID: 37481516
[TBL] [Abstract][Full Text] [Related]
4. Diffusing alpha-emitters radiation therapy in combination with temozolomide or bevacizumab in human glioblastoma multiforme xenografts.
Nishri Y; Vatarescu M; Luz I; Epstein L; Dumančić M; Del Mare S; Shai A; Schmidt M; Deutsch L; Den RB; Kelson I; Keisari Y; Arazi L; Cooks T; Domankevich V
Front Oncol; 2022; 12():888100. PubMed ID: 36237307
[TBL] [Abstract][Full Text] [Related]
5. Assessing tumor angiogenesis using dynamic contrast-enhanced integrated magnetic resonance-positron emission tomography in patients with non-small-cell lung cancer.
Huang YS; Chen JL; Chen HM; Yeh LH; Shih JY; Yen RF; Chang YC
BMC Cancer; 2021 Apr; 21(1):348. PubMed ID: 33794813
[TBL] [Abstract][Full Text] [Related]
6. Blood cell parameters as prognostic predictors of disease development for patients with advanced non-small cell lung cancer.
Wang L; Si H; Wang J; Feng L; Zhai W; Dong S; Yu Z
Oncol Lett; 2020 Aug; 20(2):1101-1110. PubMed ID: 32724349
[TBL] [Abstract][Full Text] [Related]
7. High neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio predict poor survival in rectal cancer patients receiving neoadjuvant concurrent chemoradiotherapy.
Ke TM; Lin LC; Huang CC; Chien YW; Ting WC; Yang CC
Medicine (Baltimore); 2020 Apr; 99(17):e19877. PubMed ID: 32332656
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of lymphocyte-to-monocyte ratio and platelet-to-lymphocyte ratio in patients with hepatocellular carcinoma undergoing transcatheter arterial chemoembolization and radiofrequency ablation.
Shen Y; Wang H; Chen X; Li W; Chen J
Onco Targets Ther; 2019; 12():7129-7137. PubMed ID: 31564897
[TBL] [Abstract][Full Text] [Related]
9. Total lymphocyte count, neutrophil-lymphocyte ratio, and platelet-lymphocyte ratio as prognostic factors in advanced non-small cell lung cancer with chemoradiotherapy.
Song X; Chen D; Yuan M; Wang H; Wang Z
Cancer Manag Res; 2018; 10():6677-6683. PubMed ID: 30584362
[TBL] [Abstract][Full Text] [Related]
10. Association of specific gene mutations derived from machine learning with survival in lung adenocarcinoma.
Cho HJ; Lee S; Ji YG; Lee DH
PLoS One; 2018; 13(11):e0207204. PubMed ID: 30419062
[TBL] [Abstract][Full Text] [Related]
11. Enhanced Anticancer Activity of PF-04691502, a Dual PI3K/mTOR Inhibitor, in Combination With VEGF siRNA Against Non-small-cell Lung Cancer.
Espana-Serrano L; Chougule MB
Mol Ther Nucleic Acids; 2016 Nov; 5(11):e384. PubMed ID: 27845769
[TBL] [Abstract][Full Text] [Related]
12. Myoferlin expression in non-small cell lung cancer: Prognostic role and correlation with VEGFR-2 expression.
Song DH; Ko GH; Lee JH; Lee JS; Lee GW; Kim HC; Yang JW; Heo RW; Roh GS; Han SY; Kim DC
Oncol Lett; 2016 Feb; 11(2):998-1006. PubMed ID: 26893682
[TBL] [Abstract][Full Text] [Related]
13. VEGF silencing inhibits human osteosarcoma angiogenesis and promotes cell apoptosis via PI3K/AKT signaling pathway.
Zhao J; Zhang ZR; Zhao N; Ma BA; Fan QY
Int J Clin Exp Med; 2015; 8(8):12411-7. PubMed ID: 26550152
[TBL] [Abstract][Full Text] [Related]
14. A method to assess target gene involvement in angiogenesis in vitro and in vivo using lentiviral vectors expressing shRNA.
Blosser W; Vakana E; Wyss LV; Swearingen ML; Stewart J; Stancato L; Tate CM
PLoS One; 2014; 9(4):e96036. PubMed ID: 24759702
[TBL] [Abstract][Full Text] [Related]
15. Exogenous norepinephrine attenuates the efficacy of sunitinib in a mouse cancer model.
Deng GH; Liu J; Zhang J; Wang Y; Peng XC; Wei YQ; Jiang Y
J Exp Clin Cancer Res; 2014 Feb; 33(1):21. PubMed ID: 24555849
[TBL] [Abstract][Full Text] [Related]
16. VEGF is an important mediator of tumor angiogenesis in malignant lesions in a genetically engineered mouse model of lung adenocarcinoma.
Majeti BK; Lee JH; Simmons BH; Shojaei F
BMC Cancer; 2013 Apr; 13():213. PubMed ID: 23627488
[TBL] [Abstract][Full Text] [Related]
17. Combination of a MEK inhibitor at sub-MTD with a PI3K/mTOR inhibitor significantly suppresses growth of lung adenocarcinoma tumors in Kras(G12D-LSL) mice.
Simmons BH; Lee JH; Lalwani K; Giddabasappa A; Snider BA; Wong A; Lappin PB; Eswaraka J; Kan JL; Christensen JG; Shojaei F
Cancer Chemother Pharmacol; 2012 Aug; 70(2):213-20. PubMed ID: 22684718
[TBL] [Abstract][Full Text] [Related]
18. VEGF neutralizing aerosol therapy in primary pulmonary adenocarcinoma with K-ras activating-mutations.
Hervé V; Rabbe N; Guilleminault L; Paul F; Schlick L; Azzopardi N; Duruisseaux M; Fouquenet D; Montharu J; Redini F; Paintaud G; Lemarié E; Cadranel J; Wislez M; Heuzé-Vourc'h N
MAbs; 2014; 6(6):1638-48. PubMed ID: 25484066
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
